India’s first COVID-19 vaccine candidate cleared for human trials
submited by
Style Pass
Coronavirus LIVE Updates: India’s ‘first’ indigenous COVID-19 vaccine COVAXIN, developed by city-based Bharat Biotech in collaboration with ICMR and NIV, has got the nod for human clinical trials from the Drug Controller General of India. The Phase I and Phase II clinical trials of the vaccine for SARS-CoV-2, would start across the country next month.…
Read more peppertales....
/cdn.vox-cdn.com/uploads/chorus_asset/file/25417835/51684715392_2615642caa_o.jpg)
